Stereotaxis (STXS) EBITDA (2010 - 2026)
Stereotaxis (STXS) posted quarterly EBITDA of -$6.0 million for Q1 2026, down 0.88% year-over-year from -$6.0 million in Q1 2025, and down 5.88% quarter-over-quarter from -$5.6 million in Q4 2025.
Stereotaxis (STXS) EBITDA (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported EBITDA for 17 consecutive years, with -$6.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA fell 0.88% year-over-year to -$6.0 million; the TTM figure through Mar 2026 stood at -$22.2 million (up 14.5% YoY), while the FY2025 annual figure was -$22.1 million, up 10.62% from the prior year.
- EBITDA fell to -$6.0 million in Q1 2026 per STXS's latest filing, from -$5.6 million in the prior quarter.
- Across five years, EBITDA topped out at -$4.0 million in Q2 2025 and bottomed at -$7.6 million in Q4 2024.
- Historically, EBITDA has averaged -$5.5 million across 5 years, with a median of -$5.6 million in 2023.
- Annual changes were most pronounced in 2022 — EBITDA tumbled 167.6% — and 2025, when it surged 33.95%.
- Stereotaxis' EBITDA stood at -$4.5 million in 2022, then retreated by 19.03% to -$5.3 million in 2023, then plunged by 43.8% to -$7.6 million in 2024, then grew by 25.93% to -$5.6 million in 2025, then dropped by 5.88% to -$6.0 million in 2026.
- Business Quant data shows STXS's EBITDA at -$6.0 million in Q1 2026, -$5.6 million in Q4 2025, and -$6.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.68 Bn | 129.47 Bn | 1.96 Bn | 971.90 Mn |
| 2 | Becton Dickinson | 52.46 Bn | 51.59 Bn | 2.32 Bn | 663.00 Mn |
| 3 | Alcon | 35.84 Bn | 34.49 Bn | 1.68 Bn | 11.00 Mn |
| 4 | Resmed | 33.87 Bn | 32.40 Bn | 861.22 Mn | 448.71 Mn |
| 5 | Medline | 28.95 Bn | 26.27 Bn | 2.22 Bn | 395.00 Mn |
| 6 | West Pharmaceutical Services | 25.14 Bn | 24.71 Bn | 329.20 Mn | 179.10 Mn |
| 7 | Solventum | 15.35 Bn | 14.95 Bn | 1.29 Bn | 181.00 Mn |
| 8 | Cooper Companies | 14.90 Bn | 14.77 Bn | 735.40 Mn | -31.00 Mn |
| 9 | Baxter International | 13.66 Bn | 11.51 Bn | 1.03 Bn | 217.00 Mn |
| 10 | Stereotaxis | 140.92 Mn | 126.30 Mn | 3.79 Mn | -5.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.98 Mn |
| Dec 31, 2025 | -5.65 Mn |
| Sep 30, 2025 | -6.56 Mn |
| Jun 30, 2025 | -3.98 Mn |
| Mar 31, 2025 | -5.93 Mn |
| Dec 31, 2024 | -7.63 Mn |
| Sep 30, 2024 | -6.35 Mn |
| Jun 30, 2024 | -6.02 Mn |
| Mar 31, 2024 | -4.75 Mn |
| Dec 31, 2023 | -5.30 Mn |
| Sep 30, 2023 | -5.64 Mn |
| Jun 30, 2023 | -5.28 Mn |
| Mar 31, 2023 | -5.62 Mn |
| Dec 31, 2022 | -4.46 Mn |
| Sep 30, 2022 | -5.05 Mn |
| Jun 30, 2022 | -5.18 Mn |
| Mar 31, 2022 | -4.09 Mn |
| Dec 31, 2021 | -3.35 Mn |
| Sep 30, 2021 | -4.62 Mn |
| Jun 30, 2021 | -3.39 Mn |